Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA6 | P17658 | 9/20 | 0.42 |
| ▸ | KCNA3 | P22001 | 9/20 | 0.42 |
| ▸ | KCNA4 | P22459 | 9/20 | 0.42 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.42 |
| ▸ | NT5E | P21589 | 2/20 | 0.40 |
| ▸ | KCNA2 | P16389 | 1/20 | 0.40 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oroidin SCHEMBL12597862 | 0.79 | KCNA6 (0.65) | KCNA6KCNA3KCNA4KCNA5NT5E | |
| Oroidin SCHEMBL14536687 | 0.79 | KCNA6 (0.65) | KCNA6KCNA3KCNA4KCNA5NT5E | |
| Oroidin SCHEMBL28891358 | 0.79 | KCNA6 (0.65) | KCNA6KCNA3KCNA4KCNA5NT5E | |
| SCHEMBL12598178 | 0.78 | KCNA6 (0.41) | KCNA6KCNA3KCNA4KCNA5NT5E | |
| SCHEMBL13036735 | 0.78 | KCNA6 (0.67) | KCNA6KCNA3KCNA4KCNA5NT5E | |
| SCHEMBL14114457 | 0.72 | KCNA6 (0.45) | KCNA6KCNA3KCNA4KCNA5NT5E | |
| SCHEMBL28891360 | 0.64 | — | — | |
| SCHEMBL12598174 | 0.63 | AOC1 (0.40) | — | |
| SCHEMBL18120921 | 0.63 | KMT2A (0.50) | MEN1KMT2AALDH1A1LMNAMAPT | |
| Hydrochloric Acid SCHEMBL1518219 | 0.61 | AOC1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110150819-A1 | INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE DERIVATIVES | MELANDER CHRISTIAN | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110150819-A1 | INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE DERIVATIVES | O60361, TFPI, BLVRB | KCNA6 2338/4885KCNA3 2208/4885KCNA4 3513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.